Q: What is Somavert used for?

Somavert is used to treat acromegaly .

Q: How does Somavert work?

Mechanism of Action Somavert is a growth hormone receptor antagonist. To understand how it works, it is helpful to look at how the body normally processes growth hormone. In people with acromegaly, the body produces too much growth hormone. This excess hormone travels through the bloodstream and attaches to specific receptors on the surface of cells. When growth hormone binds to these receptors, it signals the body to produce insulin-like growth factor-I (IGF-I). High levels of IGF-I lead to the excessive growth of bones and tissues characteristic of acromegaly. Somavert is designed to interfere with this process in the following ways: Blocking Receptors: Somavert is a modified version of human growth hormone. It is shaped in a way that allows it to bind to growth hormone receptors, but it does not trigger the signal to produce IGF-I. Preventing Binding: By occupying these receptor sites, Somavert prevents the body's natural growth hormone from attaching to them. Lowering IGF-I Levels: Because the receptors are blocked, the production of IGF-I decreases. This helps to reduce or control the physical changes and symptoms associated with the condition. Somavert does not stop the body from producing growth hormone; instead, it prevents the hormone that is already present from doing its job.

Q: What are the active ingredients in Somavert?

The active ingredient in Somavert is pegvisomant .

Q: What are the side effects of Somavert?

Common side effects of Somavert may include: injection site reactions diarrhea nausea Always consult with a healthcare professional about potential side effects.

Q: What drug class is Somavert?

Somavert belongs to the growth hormone receptor antagonist drug class.

Q: Is Somavert safe during pregnancy and breastfeeding?

Pregnancy There are no adequate and well-controlled studies of Somavert in pregnant women. Research in animals has shown that very high doses of the medication may have some effects on fetal development, though these doses were significantly higher than those typically used in humans. If you are pregnant or planning to become pregnant, you should discuss the potential risks and benefits with your healthcare provider to determine if the medication is necessary. Breastfeeding It is currently unknown if Somavert is excreted in human breast milk. Because the effects on a nursing infant are not well understood, it is important to consult with a healthcare professional to determine if you should continue breastfeeding while using this medication. A decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

Q: What forms and strengths does Somavert come in?

Available Forms Somavert is available in the following form: Powder for Injection: This medication comes as a sterile, freeze-dried powder or cake in a single-dose glass vial. Administration and Packaging Somavert is intended for subcutaneous injection. To prepare the dose, the powder must be mixed with a specific liquid. The medication is typically packaged in a kit that includes: A single-dose vial containing the medication powder. A prefilled syringe containing the diluent (Sterile Water for Injection) used to dissolve the powder. Once the powder is mixed with the liquid, the solution should be used immediately. Because the vials are for single use only, any unused portion of the medication must be discarded.

Q: What is the FDA approval status of Somavert?

FDA Approval Status Somavert was approved by the U.S. Food and Drug Administration (FDA) in 2003. It is a growth hormone receptor antagonist designed to lower levels of insulin-like growth factor-I (IGF-I) in the blood. Approved Indications The FDA has approved Somavert for the treatment of acromegaly in patients who have had an inadequate response to surgery or radiation therapy, or for whom these treatments are not appropriate. The clinical objective is to normalize serum IGF-I levels to manage the symptoms and progression of the disease. Regulatory Monitoring and Safety Requirements Liver Function Testing: The FDA-approved labeling requires healthcare providers to perform liver tests (including ALT, AST, serum total bilirubin, and alkaline phosphatase) before a patient begins treatment. Periodic monitoring of liver enzymes is required throughout the course of therapy because the medication can cause elevations in liver tests. Boxed Warnings and REMS: Somavert does not currently carry a Boxed Warning, which is the FDA's most serious type of warning. There is also no Risk Evaluation and Mitigation Strategy (REMS) program required for this medication. Administration: This medication is approved for subcutaneous (under the skin) injection and is available only with a valid prescription from a healthcare provider.

Question 1

What is Somavert?

Accepted Answer

Somavert contains the active ingredient pegvisomant, which belongs to a class of medications known as growth hormone receptor antagonists. It works by binding to growth hormone receptors on cell surfaces, which prevents natural growth hormone from attaching and signaling the cell.

This action helps to regulate the production of insulin-like growth factor-I (IGF-I) in the body. By interfering with these hormonal pathways, the medication helps control the physiological effects associated with overactive growth hormone signaling.

Question 2

What is Somavert used for?

Accepted Answer

Somavert is used to treat acromegaly.

Question 3

How does Somavert work?

Accepted Answer

Mechanism of Action

Somavert is a growth hormone receptor antagonist. To understand how it works, it is helpful to look at how the body normally processes growth hormone.

In people with acromegaly, the body produces too much growth hormone. This excess hormone travels through the bloodstream and attaches to specific receptors on the surface of cells. When growth hormone binds to these receptors, it signals the body to produce insulin-like growth factor-I (IGF-I). High levels of IGF-I lead to the excessive growth of bones and tissues characteristic of acromegaly.

Somavert is designed to interfere with this process in the following ways:

Blocking Receptors: Somavert is a modified version of human growth hormone. It is shaped in a way that allows it to bind to growth hormone receptors, but it does not trigger the signal to produce IGF-I.
Preventing Binding: By occupying these receptor sites, Somavert prevents the body's natural growth hormone from attaching to them.
Lowering IGF-I Levels: Because the receptors are blocked, the production of IGF-I decreases. This helps to reduce or control the physical changes and symptoms associated with the condition.

Somavert does not stop the body from producing growth hormone; instead, it prevents the hormone that is already present from doing its job.

Question 4

What are the active ingredients in Somavert?

Accepted Answer

The active ingredient in Somavert is pegvisomant.

Question 5

What are the side effects of Somavert?

Accepted Answer

Common side effects of Somavert may include:

injection site reactions
diarrhea
nausea

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Somavert?

Accepted Answer

Somavert belongs to the growth hormone receptor antagonist drug class.

Question 7

What is the dosage of Somavert and how do I take it?

Accepted Answer

Administration

Somavert is administered as a subcutaneous injection, which means it is injected into the fatty tissue just under the skin. It is usually taken once a day. Your healthcare provider will provide training on how to properly prepare the injection and where to give it.

The medication comes as a powder that must be mixed with a specific liquid diluent before use. When mixing, gently swirl the vial. Do not shake the vial, as this can make the medication less effective. Once mixed, the solution should be used immediately. If the liquid is cloudy or contains particles after mixing, it should not be used.

Rotating Injection Sites

It is important to change the location of the injection each time you use the medication. Common injection sites include the thighs, abdomen, buttocks, and upper arms. Rotating these sites helps prevent skin irritation or the development of lumps under the skin.

Missed Dose Guidance

If you forget a dose, administer it as soon as you realize it. If it is almost time for your next dose, skip the missed one and return to your usual daily schedule. Do not administer two doses at the same time to compensate for a missed one.

Storage and Handling

The medication should be stored in the refrigerator and protected from light. Do not freeze the vials. Before preparing a dose, you may allow the vial to reach room temperature, but the medication should be used promptly once mixed.

Question 8

Is Somavert safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

There are no adequate and well-controlled studies of Somavert in pregnant women. Research in animals has shown that very high doses of the medication may have some effects on fetal development, though these doses were significantly higher than those typically used in humans. If you are pregnant or planning to become pregnant, you should discuss the potential risks and benefits with your healthcare provider to determine if the medication is necessary.

Breastfeeding

It is currently unknown if Somavert is excreted in human breast milk. Because the effects on a nursing infant are not well understood, it is important to consult with a healthcare professional to determine if you should continue breastfeeding while using this medication. A decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

Question 9

What forms and strengths does Somavert come in?

Accepted Answer

Available Forms

Somavert is available in the following form:

Powder for Injection: This medication comes as a sterile, freeze-dried powder or cake in a single-dose glass vial.

Administration and Packaging

Somavert is intended for subcutaneous injection. To prepare the dose, the powder must be mixed with a specific liquid. The medication is typically packaged in a kit that includes:

A single-dose vial containing the medication powder.
A prefilled syringe containing the diluent (Sterile Water for Injection) used to dissolve the powder.

Once the powder is mixed with the liquid, the solution should be used immediately. Because the vials are for single use only, any unused portion of the medication must be discarded.

Question 10

What is the FDA approval status of Somavert?

Accepted Answer

FDA Approval Status

Somavert was approved by the U.S. Food and Drug Administration (FDA) in 2003. It is a growth hormone receptor antagonist designed to lower levels of insulin-like growth factor-I (IGF-I) in the blood.

Approved Indications

The FDA has approved Somavert for the treatment of acromegaly in patients who have had an inadequate response to surgery or radiation therapy, or for whom these treatments are not appropriate. The clinical objective is to normalize serum IGF-I levels to manage the symptoms and progression of the disease.

Regulatory Monitoring and Safety Requirements

Liver Function Testing: The FDA-approved labeling requires healthcare providers to perform liver tests (including ALT, AST, serum total bilirubin, and alkaline phosphatase) before a patient begins treatment. Periodic monitoring of liver enzymes is required throughout the course of therapy because the medication can cause elevations in liver tests.
Boxed Warnings and REMS: Somavert does not currently carry a Boxed Warning, which is the FDA's most serious type of warning. There is also no Risk Evaluation and Mitigation Strategy (REMS) program required for this medication.
Administration: This medication is approved for subcutaneous (under the skin) injection and is available only with a valid prescription from a healthcare provider.

Question 11

What should I know about Somavert and cost?

Accepted Answer

Factors Influencing Cost

Several factors can determine the final price you pay for Somavert, including:

Dosage: Somavert is available in several strengths, including 10 mg, 15 mg, 20 mg, 25 mg, and 30 mg vials. The prescribed dose will influence the total cost.
Insurance Coverage: Your specific health insurance plan, including your deductible and co-payment or co-insurance requirements, will significantly impact your out-of-pocket expenses.
Pharmacy Type: This medication is typically distributed through specialty pharmacies rather than standard retail pharmacies, which may affect pricing and delivery options.

Financial Assistance Programs

Because Somavert is a specialty drug, financial assistance may be available to help manage costs:

Manufacturer Support: The drug manufacturer may offer patient assistance programs or co-pay savings cards for eligible patients with commercial insurance.
Patient Assistance Foundations: Non-profit organizations may provide grants or support for individuals who meet specific income and medical criteria and are uninsured or underinsured.

Insurance Requirements

Most insurance companies require a process called prior authorization for Somavert. This means your healthcare provider must provide documentation to the insurance company explaining why the medication is medically necessary before the insurer will agree to cover the cost. It is important to check with your insurance provider to understand your specific coverage details.

Somavert

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

Found an Error?

Find Discounts for Somavert

Hospitals.net Disclosure